CombiGene AB (publ) (COMBI.ST)
SEK 2.7
(-0.74%)
SEK 2.7
(-0.74%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | -30.55 Million | -16.66 Million | 22.11 Million | -38.34 Million | -21.6 Million | 227.59 Thousand |
| Net Income | -38.59 Million | -6.94 Million | 20.96 Million | -28.15 Million | -17.69 Million | -13.18 Million |
| Depreciation & Amortization | 2.62 Million | 2.59 Million | 2.59 Million | 2.49 Million | 1.16 Million | - |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | 3.69 Million | -1.4 Million | -1.44 Million | -11.28 Million | -4.84 Million | 13.37 Million |
| Other non-cash items | 2.48 Million | -10.9 Million | 24.00 | -1.39 Million | -237.04 Thousand | 34.58 Thousand |
| Investing Cash Flow | -988.9 Thousand | - | -147.73 Thousand | -3.21 Million | -1.52 Million | -430.2 Thousand |
| Investments in PPE | -108.9 Thousand | - | -147.73 Thousand | -104.34 Thousand | - | -430.2 Thousand |
| Acquisitions | -880 Thousand | - | - | -3.1 Million | -1.52 Million | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | -994 Thousand | - | -147.73 Thousand | -104.34 Thousand | - | -430.2 Thousand |
| Financing Cash Flow | 545.00 | - | 65.88 Million | 75.28 Million | 6.48 Million | 27.08 Million |
| Debt repayment | - | - | - | -7 Million | -7 Million | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | -392.71 Thousand | - |
| Common Stock Issuance | - | - | 65.88 Million | 82.28 Million | -392.71 Thousand | 27.08 Million |
| Other Financing Activities | - | - | 65.88 Million | 75.28 Million | 6.48 Million | 27.08 Million |
| Accounts receivables | 5.64 Million | 438.94 Thousand | -999.72 Thousand | -2.75 Million | -1.58 Million | 339.8 Thousand |
| Accounts payables | -1.94 Million | -1.84 Million | -445.2 Thousand | -8.53 Million | - | 13.03 Million |
| Inventory | - | 1.84 Million | 445.2 Thousand | 8.53 Million | - | - |
| Other working capital | -1.94 Million | -1.84 Million | -445.2 Thousand | -8.53 Million | -3.25 Million | 13.03 Million |
| Cash at beginning of period | 131.77 Million | 136.74 Million | 48.89 Million | 15.16 Million | 31.8 Million | 4.91 Million |
| Cash at end of period | 101.44 Million | 131.77 Million | 136.74 Million | 48.89 Million | 15.16 Million | 31.8 Million |
| Capital Expenditure | -108.9 Thousand | - | -147.73 Thousand | -104.34 Thousand | - | -430.2 Thousand |
| Effect of forex changes on cash | 1.21 Million | 11.69 Million | - | - | 1.00 | - |
| Net cash flow / Change in cash | -30.33 Million | -4.96 Million | 87.84 Million | 33.72 Million | -16.63 Million | 26.88 Million |
| Free Cash Flow | -30.66 Million | -16.66 Million | 21.96 Million | -38.44 Million | -21.6 Million | -202.6 Thousand |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | - | -14.19 Million | -38.59 Million | -6.36 Million | -8.4 Million | -6.28 Million |
| Depreciation & Amortization | - | 693 Thousand | 2.62 Million | 678 Thousand | 649 Thousand | 649 Thousand |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | - | - | 3.69 Million | 3.69 Million | - | - |
| Other non-cash items | -7.86 Million | 3.56 Million | 2.48 Million | -1.31 Million | 549 Thousand | -422 Thousand |
| Investing Cash Flow | - | - | -988.9 Thousand | -874.9 Thousand | - | -5000.00 |
| Investments in PPE | - | - | -108.9 Thousand | - | - | - |
| Acquisitions | - | - | -880 Thousand | -880 Thousand | - | - |
| Investment purchases | - | - | - | - | - | - |
| Sales/Maturities of investments | - | - | - | - | - | - |
| Other Investing Activities | - | - | -994 Thousand | -880 Thousand | - | -5000.00 |
| Financing Cash Flow | - | - | 545.00 | 1000.00 | - | -194 Thousand |
| Debt repayment | - | - | - | - | - | - |
| Dividends payments | - | - | - | - | - | - |
| Common Stock Repurchased | - | - | - | - | - | - |
| Common Stock Issuance | - | - | - | - | - | - |
| Other Financing Activities | - | - | - | - | - | - |
| Accounts receivables | - | - | 5.64 Million | 5.64 Million | - | - |
| Accounts payables | - | - | -1.94 Million | - | - | - |
| Inventory | - | - | - | - | - | - |
| Other working capital | - | - | -1.94 Million | -1.94 Million | - | - |
| Cash at beginning of period | 90.31 Million | 101.44 Million | 131.77 Million | 107.18 Million | 115.25 Million | 120.5 Million |
| Cash at end of period | 83.55 Million | 90.31 Million | 101.44 Million | 101.44 Million | 107.18 Million | 115.25 Million |
| Capital Expenditure | - | - | -108.9 Thousand | - | - | - |
| Effect of forex changes on cash | 1.09 Million | -1.18 Million | 1.21 Million | 2.13 Million | -1.05 Million | 1 Million |
| Net cash flow / Change in cash | -6.76 Million | -11.12 Million | -30.33 Million | -5.74 Million | -8.06 Million | -5.25 Million |
| Free Cash Flow | -7.86 Million | -9.93 Million | -30.66 Million | -6.99 Million | -7.2 Million | -6.05 Million |
6725
0303
002559
004490
GRG
0R6H